| 1e1d |
Hybrid Cluster Protein from Desulfovibrio vulgaris |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1e |
Crystal structure of a Monocot (Maize ZMGlu1) beta-glucosidase |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1f |
Crystal structure of a Monocot (Maize ZMGlu1) beta-glucosidase in complex with p-Nitrophenyl-beta-D-thioglucoside |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1g |
Human prion protein variant M166V |
20 |
20 |
SOLUTION NMR |
| 1e1h |
Crystal Structure of recombinant Botulinum Neurotoxin Type A Light Chain, self-inhibiting Zn endopeptidase. |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1j |
Human prion protein variant M166V |
1 |
1 |
SOLUTION NMR |
| 1e1k |
ADRENODOXIN REDUCTASE in complex with NADP+ obtained by a soaking experiment |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1l |
STRUCTURE OF ADRENODOXIN REDUCTASE IN COMPLEX WITH NADP obtained by cocrystallisation |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1m |
ADRENODOXIN REDUCTASE in complex with NADPH obtained by a soaking experiment |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1n |
Structure of adrenodoxin reductase at 2.4 Angstrom in crystal form A' |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1o |
lysyl-tRNA Synthetase (LYSU) hexagonal form, complexed with lysine |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1p |
Human prion protein variant S170N |
20 |
20 |
SOLUTION NMR |
| 1e1q |
BOVINE MITOCHONDRIAL F1-ATPASE AT 100K |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1r |
BOVINE MITOCHONDRIAL F1-ATPASE INHIBITED BY MG2+ADP AND ALUMINIUM FLUORIDE |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1s |
Human prion protein variant S170N |
1 |
1 |
SOLUTION NMR |
| 1e1t |
LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM COMPLEXED WITH THE LYSYL_ADENYLATE INTERMEDIATE |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1u |
Human prion protein variant R220K |
20 |
20 |
SOLUTION NMR |
| 1e1v |
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1w |
Human prion protein variant R220K |
1 |
1 |
SOLUTION NMR |
| 1e1x |
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1y |
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site |
1 |
1 |
X-RAY DIFFRACTION |
| 1e1z |
Crystal structure of an Arylsulfatase A mutant C69S |
1 |
1 |
X-RAY DIFFRACTION |
| 1e20 |
The FMN binding protein AtHal3 |
1 |
1 |
X-RAY DIFFRACTION |
| 1e21 |
Ribonuclease 1 des1-7 Crystal Structure at 1.9A |
1 |
1 |
X-RAY DIFFRACTION |
| 1e22 |
LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM complexed with lysine and the non-hydrolysable atp analogue amp-pcp |
1 |
1 |
X-RAY DIFFRACTION |
| 1e24 |
LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM complexed with lysine and ATP and MN2+ |
1 |
1 |
X-RAY DIFFRACTION |
| 1e25 |
The high resolution structure of PER-1 class A beta-lactamase |
1 |
1 |
X-RAY DIFFRACTION |
| 1e26 |
Design, Synthesis and X-ray Crystal Structure of a Potent Dual Inhibitor of Thymidylate Synthase and Dihydrofolate Reductase as an Antitumor Agent. |
1 |
1 |
X-RAY DIFFRACTION |
| 1e27 |
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM1(LPPVVAKEI) |
1 |
1 |
X-RAY DIFFRACTION |
| 1e28 |
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM2(TAFTIPSI) |
1 |
1 |
X-RAY DIFFRACTION |
| 1e29 |
PSII associated cytochrome C549 from Synechocystis sp. |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2a |
ENZYME IIA FROM THE LACTOSE SPECIFIC PTS FROM LACTOCOCCUS LACTIS |
2 |
2 |
X-RAY DIFFRACTION |
| 1e2b |
NMR STRUCTURE OF THE C10S MUTANT OF ENZYME IIB CELLOBIOSE OF THE PHOSPHOENOL-PYRUVATE DEPENDENT PHOSPHOTRANSFERASE SYSTEM OF ESCHERICHIA COLI, 17 STRUCTURES |
17 |
17 |
SOLUTION NMR |
| 1e2d |
Human thymidylate kinase complexed with thymidine monophosphate, adenosine diphosphate and a magnesium-ion |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2e |
Human thymidylate kinase complexed with thymidine monophosphate, adenosine diphosphate,a magnesium-ion and ALf3 |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2f |
Human thymidylate kinase complexed with thymidine monophosphate, adenosine diphosphate and a magnesium-ion |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2g |
Human thymidylate kinase complexed with ADP, TDP and a magnesium-ion |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2h |
The nucleoside binding site of Herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2i |
The nucleoside binding site of Herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2j |
The nucleoside binding site of Herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2k |
Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2l |
Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2m |
HPT + HMTT |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2n |
HPT + HMTT |
2 |
2 |
X-RAY DIFFRACTION |
| 1e2o |
CATALYTIC DOMAIN FROM DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2p |
Thymidine kinase, DHBT |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2q |
Human thymidylate kinase complexed with TP5A and a magnesium-ion |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2r |
CYTOCHROME CD1 NITRITE REDUCTASE, REDUCED AND CYANIDE BOUND |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2s |
Crystal structure of an Arylsulfatase A mutant C69A |
1 |
1 |
X-RAY DIFFRACTION |
| 1e2t |
Arylamine N-acetyltransferase (NAT) from Salmonella typhimurium |
2 |
2 |
X-RAY DIFFRACTION |